Bowel Diseases
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I n t r o d u c t i o n
Autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC) are immunemediated chronic liver diseases and have often been regarded as separate disease entities. It has been possible to distinguish between these autoimmune diseases based on the clinical, biochemical and histological features in the majority of cases. In recent years, however, there have been a few cases that were difficult to diagnose as a definite disease because of coexistence of diagnostic features, which is termed as overlap syndrome. While overlap syndrome of AIH and PBC is frequent among adults, overlap between AIH and PSC has rarely been reported, especially in children. Meanwhile, PSC is known to be associated with inflammatory bowel diseases (IBD) such as ulcerative colitis (UC).
We report one case of AIH-PSC overlap syndrome in a 10-year-old girl who had been diagnosed and treated for UC.
Ca s er e p o r t
A 10-year-old girl was referred with a 1-year history of diarrhea, abdominal pain and weight loss. She was found to have elevated liver enzymes in her routine school examination 2 years ago but did not undergo any clinical investigations. One year later, she was admitted to a private hospital for abdominal pain and bloody stool with diarrhea. Colonoscopic examination showed no significant findings. However, her symptoms persisted and she lost weight for about 1 year.
She was readmitted to the hospital and the second colonoscopic biopsy was performed. The diagnosis of UC was made and treatment with mesalazine was initiated 1 month prior to referral to our hospital. Colonoscopic examination revealed mucosal friability and diffuse hyperemic spots in the entire colon. Biopsy showed crypt atrophy and distortion with heavy eosinophil and lymphoplasma cell infiltration which was consistent with active UC (Fig. 1 ).
Liver biopsy showed portal lymphoplasmacytic inflammation and bridging fibrosis. A periductal edema and concentric fibrosis around the interlobular bile duct ("onion-skin appearance") was found with positive immunostaining of cytokeratin 7 and CD3, which are indicative of bile duct damage and destruction (Fig. 2) . Magnetic resonance cholangiopancreatography (MRCP) showed mild dilatation of common bile duct (maximal diameter 6.8 mm) and irregular dilatation of intrahepatic duct that was compatible with PSC ( Fig. 3) .
Diagnostic criteria for AIH were fulfilled with a score of 14 according to the revised scoring system proposed by the Fig. 3 . Magnetic resonance cholangiopancreatography reveals mild dilatation of the common bile duct (maximal diameter is 6.8 mm: arrow) and mild irregular dilatation of intra-hepatic ducts.
International Autoimmune Hepatitis Group 1) . Therefore, the diagnosis of AIH-PSC overlap syndrome accompanied by UC was made. Prednisolone (1 mg/kg/day initially, followed by .
PSC is characterized by inflammation and progressive fibrosis of the intrahepatic and/or extrahepatic bile ducts 2, 3) .
The diagnosis of PSC can be made by cholangiography and/ or histology of the liver parenchyme. The characteristic histological features are periductal "onion-skin" fibrosis and inflammation with portal edema. In recent years, MRCP has been established as the preliminary noninvasive method of diagnosing PSC, especially in children 3, 4) .
PSC is accompanied by IBD, particularly UC in about 53-81% of cases 5, 6) . Approximately 5-10% of patients with UC will have coexisting PSC 7) . The UC associated with PSC is characteristically mild, asymptomatic and runs a quiescent course. It is associated with rectal sparing and more severe right sided disease. It also has a high risk of colorectal malignancy, which necessitates routine colonoscopic surveillance 8) . Bowel symptoms may have developed before the nonspecific symptoms of PSC as fatigue, nausea and weight loss. Therefore, UC is usually diagnosed several years before PSC 7) .
In our patient who was diagnosed as having UC, we Overlap syndrome is generally defined as a condition with diagnostic features of more than one disease. In recent years, however, the term has been used to define autoimmune conditions in which clinical, biochemical and histological features of AIH, PSC or PBC are overlapped 9) . It occurs in approximately 20% of all patients with autoimmune liver diseases 10) .
AIH-PSC overlap syndromes appear to be more common in childhood 6) . Most of the reported overlap cases were originally diagnosed as AIH and the diagnosis of PSC was made years after demonstration of characteristic bile duct changes on cholangiography 5, 6, 11, 12) . Therefore, investigations should be undertaken to rule out underlying PSC in children presenting with features of AIH.
Overlap syndrome is also considered to be associated with IBD (59-89%) 5, 6) . However, the presence of IBD is not a useful parameter to screen for overlap syndrome.
AIH-PSC overlap syndrome shows good response to treatment with immunosuppressive drugs, even if they are less efficient than in AIH. Therefore, overlap syndrome should be suspected in the case of little response to immunosuppressant in a patient with AIH. Immunosuppressive therapy, such as prednisolone, together with UDCA, is often prescribed in children 5, 12) . Liver transplantation is required when a child progresses to biliary cirrhosis and hepatic decompensation 6, 12) .
Recognition of overlap syndrome is of clinical significance in case of autoimmune liver diseases or IBD to enable timely and effective treatment. Children with chronic autoimmune liver disease with high levels of serum IgG, GGT and ALP should be tested for PSC, which should be ruled out by MRCP. 
